Back to results
US 2024/0390464 A1Published application
Treatment of Adults With Overweight or Obesity With or Without Weight-Related Comorbidities
AssigneeCarmot Therapeutics Inc.
InventorsManu Chakravarthy, Alexandra Steinberg, Jingtao Wu, Michael Elliott
Life of this patent
Estimating the term…
Abstract
The present disclosure provides methods of treating overweight or obese patients with or without type 2 diabetes mellitus. The treatment comprises administration of a dual GLP-1 receptor and GIP receptor agonist.
Claims16
A method of
- managing weight,
- improving glycemic control, and/or
- increasing insulin sensitivity
- in an overweight or obese adult patient in need thereof, comprising administering by subcutaneous injection to the patient a compound of Formula I, or a pharmaceutically acceptable salt or ester thereof:
- wherein the compound is administered at a body weight-independent dose of about 2.0 mg to about 25 mg.
2 more elements
14-15. (canceled)
An article of manufacture comprising a body weight-independent dose of about 2.0 mg to about 25 mg of a compound of Formula I, or a pharmaceutically acceptable salt or ester thereof:
Dependencies are inferred from the claim text.